Newborn Screening, Newborn Screening Follow-Up | Approved June 2005
Recognizes that infant tracking and follow-up of positive cases and unsatisfactory specimens are critical parts of the newborn screening system that are integral to any program considerations concerning testing, financing and parent/provider education; endorses the follow-up considerations previously published by the American Academy of Pediatrics Newborn Screening Task Force; and supports the two published reports of the Council of Regional Networks for Genetic Services regarding newborn screening systems.
Residual Newborn Screening (NBS) Specimens | Approved June 2005
Supports the development of national consensus policies, procedures and standards for retaining residual dried blood spot specimens following newborn screening analysis. These policies and procedures must recognize existing federal regulations for clinical testing, state laws, professional guidelines and ethical and legal precedents.
Quality Assurance in a Newborn Screening Laboratory | Approved April 2005
Supports the intense efforts to assure and sustain the highest quality of testing possible for newborn screening for public health programs.
The Role of the Private Laboratory Sector in Public Health Newborn Screening Programs | Approved June 5, 2002
Screening of newborns for treatable congenital conditions is a public health program that gives states the statutory or regulatory authority to mandate screening. These screening programs require that the laboratory testing involved be carefully controlled by the state public health agencies responsible for these programs.